Haemophylus influenzae B Vacc.

Haemophilus influencae B Vacc.

Bacillus influencae Vacc.

ACT-HIB

Haem-i-b.

HIB


About Haemophylus influenzae B Vacc. 

family Pasteurellaceae 
group substance, vaccine, bacterium
starting material PEDVAX-R, hergestellt von der Firma Schmidt-Nagel, Genf
ACT-HIB, hergstellet von Aventis Pasteur MSD

Haemophilus influenzae, formerly called Pfeiffer's bacillus or Bacillus influenzae, is a non-motile Gram-negative coccobacillus first described in 1892 by Dr. Richard Pfeiffer during an influenza pandemic. It is generally aerobic, but can grow as a facultative anaerobe. H. influenzae was mistakenly considered to be the cause of the common flu until 1933, when the viral etiology of the flu became apparent. Still, H. influenzae is responsible for a wide range of clinical diseases.
Because of its small genome, H. influenzae became the first free-living organism with its entire genome sequenced. Its genome consists of 1,830,140 base pairs of DNA and contains 1740 genes. The sequencing project, completed and published in Science in 1995, was conducted at The Institute for Genomic Research under the direction of Dr. Robert Fleischmann.

Serotypes
In 1930, 2 major categories of H. influenzae were defined: the unencapsulated strains and the encapsulated strains. The pathogenesis of H. influenzae infections is not completely understood, although the presence of the encapsulated type b (HiB) is known to be the major factor in virulence. Their capsule allows them to resist phagocytosis and complement-mediated lysis in the non-immune host. Unencapsulated strains are less invasive, but they are able to induce an inflammatory response that causes disease, such as epiglottitis. Vaccination with Hib conjugate vaccines is effective in preventing infection, and several vaccines are now available for routine use.

Diseases
Most strains of H. influenzae are opportunistic pathogens - that is, they usually live in their host without causing disease, but cause problems only when other factors (such as a viral infection or reduced immune function) create an opportunity. There are six generally recognized types of H. influenzae: a, b, c, d, e, and f.
Naturally-acquired disease caused by H. influenzae seems to occur in humans only. In infants and young children, H. influenzae type B (HIB) causes bacteremia, and acute bacterial meningitis. Occasionally, it causes cellulitis, osteomyelitis, epiglottitis, and joint infections. Due to routine use of the HIB conjugate vaccine in the U.S. since 1990, the incidence of invasive HIB disease has decreased to 1.3/100,000 children. However, HIB remains a major cause of lower respiratory tract infections in infants and children in developing countries where vaccine is not widely used. Unencapsulated H. influenzae (non-B type) causes ear (otitis media) and eye (conjunctivitis) infections and sinusitis in children, and is associated with pneumoni 

potencies in stock of Haemophylus influenzae B Vacc. 

 to order select a potency
 
DGlobuli 
D12
D15
D30
D200
Dilution 
D12
D15
D30
D200
HAB 2010
CGlobuli 
C6
C7
C9
C10
C12
C15
C30
C200
1M
10M
50M
Dilution 
C6
C7
C9
C10
C12
C15
C30
C200
HAB 2010

Your selection of Haemophylus influenzae B Vacc. 

Potency 
please select potency range above first             change potency
size of unit  
Unit price  EUR
Number of units 
order remedy
order remedy and order this remedy in another potency

identification data of Haemophylus influenzae B Vacc. 

method 5a 
Remedia-Nr. 473 

Haemophylus influenzae B Vacc., Haemophilus influencae B Vacc., Bacillus influencae Vacc., ACT-HIB, Haem-i-b., HIB. REMEDIA Homeopathy.

available potencies in Globuli or Dilution:
D12, D15, D30, D200
C6, C7, C9, C10, C12, C15, C30, C200, 1M, 10M, 50M

Production of effective homeopathic remedies using the original formula.
Highest quality due to own laboratories and 250 years of experience.